Zenith Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations in the form of tablets, capsules, oral liquids and injectable. It is focused on various therapeutic areas, such as antibiotics and anti-infective, gastrointestinal, analgesic/anti-inflammatory, cardiovascular, respiratory, ophthalmology, biotechnical products, oncology, anti-retroviral, central nervous system, nutrition, Genito urinary system, and skin. Its products include general, such as general tablets, general capsules and general liquids, and beta-lactam, such as beta-lactam tablets, beta-lactam capsules and beta-lactam liquids. It also offers contract manufacturing of all dosage forms. The Company exports its products to various countries, such as Cambodia, Myanmar, Papua New Guinea, Sri Lanka, Nigeria, Gambia, Zambia, Namibia, Paraguay, Bolivia, Venezuela, Guatemala, Barbados, Jamaica, Bahamas, Yemen and Turkey.
ZENITH HEALTH CARE LTD. Financial Highlights
- Revenue: ZENITH HEALTH CARE LTD. reported revenue of ₹10.93 crore in FY26 vs ₹11.76 crore in FY25. It showed a decrease of 7.06% on a yearly basis.
- Operating Profit: ZENITH HEALTH CARE LTD. reported an operating profit of ₹0.02 crore in FY26 vs ₹0.28 crore in FY25. It showed a decrease of 92.86% on a year-on-year basis.
- Net Profit: ZENITH HEALTH CARE LTD. reported a net profit of ₹0.01 crore in FY26 vs ₹0.07 crore in FY25. It showed a decrease of 85.71% on a yearly basis.
ZENITH HEALTH CARE LTD. Quarterly Result Highlights
- ZENITH HEALTH CARE LTD. reported revenue of ₹2.72 crore in Mar 2026, compared with ₹2.52 crore in Dec 2025, representing an increase of 7.94% on a quarter-on-quarter (QoQ) basis.
- ZENITH HEALTH CARE LTD. reported an operating loss of ₹0.42 crore in Mar 2026, compared with ₹0.25 crore in Dec 2025, representing a decrease of 268.00% on a quarter-on-quarter (QoQ) basis.
- ZENITH HEALTH CARE LTD. reported a loss of ₹0.34 crore in Mar 2026, compared with ₹0.22 crore in Dec 2025, reflecting a decrease of 254.55% on a QoQ basis.
- The earnings per share (EPS) of ZENITH HEALTH CARE LTD. stood at ₹0.01 during Mar 2026.